We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

41 hedge funds and large institutions have $17.1M invested in Anixa Biosciences in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more capital invested

Capital invested by funds: $9.95M → $17.1M (+$7.14M)

55% more call options, than puts

Call options by funds: $99K | Put options by funds: $64K

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0.61% more ownership

Funds ownership: 10.73% → 11.33% (+0.61%)

9% less funds holding

Funds holding: 45 → 41 (-4)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
7
Closed
8
Calls
$99K
Puts
$64K
Net Calls
+$35K
Net Calls Change
-$71K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$793K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$89.6K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$85.8K
4
Millennium Management
Millennium Management
New York
+$69.1K
5
UBS Group
UBS Group
Switzerland
+$66K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$116K
2
CL
CPWM LLC
Washington
-$61K
3
Charles Schwab
Charles Schwab
California
-$46.3K
4
VF
Virtu Financial
New York
-$45K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.4M – – –
UBS Group
2
UBS Group
Switzerland
$3.06M +$66K +16,285 +3%
BlackRock
3
BlackRock
New York
$1.46M +$793K +195,603 +192%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.33M +$2.67K +660 +0.2%
LFCM
5
Long Focus Capital Management
Puerto Rico
$815K – – –
State Street
6
State Street
Massachusetts
$502K – – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$481K – – –
RJA
8
Raymond James & Associates
Florida
$299K -$18.9K -4,672 -7%
Northern Trust
9
Northern Trust
Illinois
$288K +$6.47K +1,597 +3%
Renaissance Technologies
10
Renaissance Technologies
New York
$281K -$116K -28,682 -33%
Morgan Stanley
11
Morgan Stanley
New York
$257K -$8K -1,975 -4%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$196K +$89.6K +22,119 +124%
CA
13
CoreCap Advisors
Michigan
$184K +$1.01K +250 +0.7%
Millennium Management
14
Millennium Management
New York
$178K +$69.1K +17,051 +89%
GAM
15
Gemmer Asset Management
California
$172K – – –
LPL Financial
16
LPL Financial
California
$108K – – –
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$104K +$85.8K +21,177 New
TSWM
18
Tyler-Stone Wealth Management
Ohio
$103K – – –
Citadel Advisors
19
Citadel Advisors
Florida
$97K -$19K -4,684 -19%
SBH
20
Segall Bryant & Hamill
Illinois
$86K – – –
BRWA
21
B. Riley Wealth Advisors
Florida
$80K +$65.6K +16,200 New
CAM
22
Concorde Asset Management
Michigan
$79K -$101 -25 -0.2%
KeyBank National Association
23
KeyBank National Association
Ohio
$76K – – –
Cambridge Investment Research Advisors
24
Cambridge Investment Research Advisors
Iowa
$74K +$60.8K +15,000 New
SWM
25
Spire Wealth Management
Virginia
$71K – – –
1
2

ANIX Hedge Fund Activity: Q3 2022 in Review

41 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2022, worth a combined $17.1M — up 72% from $9.95M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ANIX and 5 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 10 added.

The largest buyer was BlackRock, adding an estimated $793K. The largest seller was Renaissance Technologies, cutting an estimated $116K.

  • 41 institutional investors held Anixa Biosciences (ANIX) as of Q3 2022, down from 45 in Q2 2022.
  • Funds reported $17.1M of Anixa Biosciences stock for Q3 2022, up 72% quarter-over-quarter.
  • 5 funds opened new Anixa Biosciences positions in Q3 2022 and 8 closed out, a net change of -3 holders.
  • The largest Anixa Biosciences buyer in Q3 2022 was BlackRock, an estimated $793K added.
  • The largest Anixa Biosciences seller in Q3 2022 was Renaissance Technologies, an estimated $116K sold.

Based on aggregated 13F filings for Q3 2022.